文献速递腹部MRCTUS

肝细胞腺瘤:分子基础与多模态影像学更新

Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update.
PubMed 文献 · Radiographics · 2023-01-01

肝细胞腺瘤(HCA)依据分子分析可分为八种基因型亚型,各亚型细胞生物学改变独特,决定临床病程并可能实现无创识别。多期MRI联合肝胆对比剂是HCA无创检测、表征和监测的最佳方法,HCA在肝胆期通常呈低信号,但β-catenin突变外显子3亚型和高达三分之一的炎症型HCA例外。出血和恶变为肝细胞癌是最值得担忧的两种并发症,风险取决于肿瘤大小、亚型和临床因素;对于持续大于5 cm的HCA、男性任何大小的腺瘤以及所有β-catenin突变外显子3 HCA,推荐择期手术切除。

要点

  • HCA在肝胆期通常呈低信号,但β-catenin突变外显子3亚型和高达三分之一的炎症型HCA例外。
  • 多期MRI联合肝胆对比剂是HCA无创检测、表征和监测的最佳方法。
  • 持续大于5 cm的HCA、男性任何大小的腺瘤及所有β-catenin突变外显子3 HCA推荐择期手术切除。

核心结论

  • HCA依据分子分析分为八种基因型亚型,各亚型细胞生物学改变独特,决定临床病程并可能实现无创识别;多期MRI联合肝胆对比剂是无创检测、表征和监测HCA的最佳方法;出血和恶变是最值得担忧的并发症,风险取决于肿瘤大小、亚型和临床因素;持续大于5 cm的HCA、男性任何大小的腺瘤及所有β-catenin突变外显子3 HCA推荐择期手术切除,热消融和经动脉栓塞是手术切除的潜在替代方案。

研究设计与样本

  • 本文为关于肝细胞腺瘤的综述,涵盖按亚型和影像模态的放射-病理相关性、相关并发症及管理推荐。
  • HCA分类已扩展,现基于分子分析发现包括八种不同的基因型亚型。

关键影像表现/征象

  • HCA在肝胆期通常呈低信号,但β-catenin突变外显子3亚型和高达三分之一的炎症型HCA例外。
  • HCA通常首先通过其他影像模态发现,理解其在MRI以外的表现很重要。

诊断标准与关键数值

  • 持续大于5 cm的HCA推荐择期手术切除。
  • 男性任何大小的腺瘤推荐择期手术切除。
  • 所有β-catenin突变外显子3 HCA推荐择期手术切除。
  • 热消融和经动脉栓塞是手术切除的潜在替代方案。
  • HCA破裂急性期,患者通常接受经动脉栓塞,伴或不伴延迟手术切除。

临床应用与阅片要点

  • 多期MRI联合肝胆对比剂是无创检测、表征和监测HCA的最佳方法。
  • HCA在肝胆期通常呈低信号,但β-catenin突变外显子3亚型和高达三分之一的炎症型HCA例外。
  • HCA通常首先通过其他影像模态发现,理解其在MRI以外的表现很重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular adenomas (HCAs) are a family of liver tumors that are associated with variable prognoses. Since the initial description of these tumors, the classification of HCAs has expanded and now includes eight distinct genotypic subtypes based on molecular analysis findings. These genotypic subtypes have unique derangements in their cellular biologic makeup that determine their clinical course and may allow noninvasive identification of certain subtypes. Multiphasic MRI performed with hepatobiliary contrast agents remains the best method to noninvasively detect, characterize, and monitor HCAs. HCAs are generally hypointense during the hepatobiliary phase; the β-catenin-mutated exon 3 subtype and up to a third of inflammatory HCAs are the exception to this characterization. It is important to understand the appearances of HCAs beyond their depictions at MRI, as these tumors are typically identified with other imaging modalities first. The two most feared related complications are bleeding and malignant transformation to hepatocellular carcinoma, although the risk of these complications depends on tumor size, subtype, and clinical factors. Elective surgical resection is recommended for HCAs that are persistently larger than 5 cm, adenomas of any size in men, and all β-catenin-mutated exon 3 HCAs. Thermal ablation and transarterial embolization are potential alternatives to surgical resection. In the acute setting of a ruptured HCA, patients typically undergo transarterial embolization with or without delayed surgical resection. This update on HCAs includes a review of radiologic-pathologic correlations by subtype and imaging modality, related complications, and management recommendations. © RSNA, 2023 Online supplemental material is available for this article. Quiz questions for this article are available through the Online Learning Center.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Tse JR, Felker ER, Naini BV, et al. Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update. Radiographics. 2023. PMID: 36821508. doi:10.1148/rg.220134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。